Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Abstract Purpose To develop a European White Paper document on oropharyngeal
dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the …

Background The present study uses population‐based data from the Surveillance,
Epidemiology, and End Results (SEER) database to evaluate the behavior of sinonasal …

Background Malignant tumours arising within the nasal cavity and paranasal sinuses are
rare and composed of several histological types, rendering controlled clinical trials to …

Objective To evaluate the oncologic outcomes of patients with sinonasal cancer treated with
endoscopic resection. Design Retrospective review. Setting Tertiary care academic cancer …

Since its introduction more than a decade ago, intensity-modulated radiotherapy (IMRT) has
spread to most radiotherapy departments worldwide for a wide range of indications. The …

BACKGROUND Sinonasal malignancies are a rare and heterogeneous group of tumors for
which there is a paucity of robust data with which to guide management decisions. The …

Objectives/Hypothesis To examine the incidence and survival of patients with sinonasal
squamous cell carcinoma (SNSCC) between the years of 1973 and 2009 using the …

Background Sinonasal cancer (SNC) has been related to occupational exposures, but the
relative risk associated to specific jobs and/or carcinogen exposures other than wood and …